Th9 Cell Differentiation and Its Dual Effects in Tumor Development
Authors:
Open Access
- 20 May 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 1026
Abstract
With the improved understanding of the molecular pathogenesis and characteristics of cancers, the critical role of the immune system in preventing tumor development has been widely accepted. The understanding of the relationship between the immune system and cancer progression is constantly evolving, from the cancer immunosurveillance hypothesis to immunoediting theory and the delicate balance in the tumor microenvironment. Currently, immunotherapy is regarded as a promising strategy against cancers. Although adoptive cell therapy (ACT) has shown some exciting results regarding the rejection of tumors, the effect is not always satisfactory. Cellular therapy with CD4+ T cells remains to be further explored since the current ACT is mainly focused on CD8+ cytotoxic T lymphocytes (CTLs). Recently, Th9 cells, a subgroup of CD4+ T helper cells characterized by the secretion of IL-9 and IL-10, have been reported to be effective in the elimination of solid tumors and to exhibit superior antitumor properties to Th1 and Th17 cells. In this review, we summarize the most recent advances in the understanding of Th9 cell differentiation and the dual role, both anti-tumor and pro-tumor effects, of Th9 cells in tumor progression.Keywords
This publication has 125 references indexed in Scilit:
- BATF–JUN is critical for IRF4-mediated transcription in T cellsNature, 2012
- Notch Receptors and Smad3 Signaling Cooperate in the Induction of Interleukin-9-Producing T CellsImmunity, 2012
- Control of the differentiation of regulatory T cells and TH17 cells by the DNA-binding inhibitor Id3Nature Immunology, 2010
- The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammationNature Immunology, 2010
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor ImmunityImmunity, 2009
- IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cellsNature Immunology, 2008
- Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell ProgramsImmunity, 2008
- Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancerBritish Journal of Cancer, 2007
- Direct Regulation of Gata3 Expression Determines the T Helper Differentiation Potential of NotchImmunity, 2007
- Notch Directly Regulates Gata3 Expression during T Helper 2 Cell DifferentiationImmunity, 2007